The challenges of long-distance axon regeneration in the injured CNS
The challenges of long-distance axon regeneration in the injured CNS
Injury to the central nervous system (CNS) that results in long-tract axonal damage typically leads to permanent functional deficits in areas innervated at, and below, the level of the lesion. The initial ischemia, inflammation, and neurodegeneration are followed by a progressive generation of scar tissue, dieback of transected axons, and demyelination, creating an area inhibitory to regrowth and recovery. Two ways to combat this inhibition is to therapeutically target the extrinsic and intrinsic properties of the axon-scar environment. Scar tissue within and surrounding the lesion site can be broken down using an enzyme known as chondroitinase. Negative regulators of adult neuronal growth, such as Nogo, can be neutralized with antibodies. Both therapies greatly improve functional recovery in animal models. Alternatively, modifying the intrinsic growth properties of CNS neurons through gene therapy or pharmacotherapy has also shown promising axonal regeneration after injury. Despite these promising therapies, the main challenge of long-distance axon regeneration still remains; achieving a level of functional and organized connectivity below the level of the lesion that mimics the intact CNS.
CNS regeneration, glial scar , PTEN, spinal cord injury, integrins, Nogo
253-294
Chew, Daniel J.
9b105524-f81d-42fd-9253-950926b5b87f
Fawcett, James W.
4549730e-9f62-45b8-820b-8a9c98d1058b
Andrews, Melissa R.
ae987a2f-878e-4ae3-a7a3-a7170712096c
2012
Chew, Daniel J.
9b105524-f81d-42fd-9253-950926b5b87f
Fawcett, James W.
4549730e-9f62-45b8-820b-8a9c98d1058b
Andrews, Melissa R.
ae987a2f-878e-4ae3-a7a3-a7170712096c
Chew, Daniel J., Fawcett, James W. and Andrews, Melissa R.
(2012)
The challenges of long-distance axon regeneration in the injured CNS.
Progress in Brain Research, 201, .
(doi:10.1016/B978-0-444-59544-7.00013-5).
Abstract
Injury to the central nervous system (CNS) that results in long-tract axonal damage typically leads to permanent functional deficits in areas innervated at, and below, the level of the lesion. The initial ischemia, inflammation, and neurodegeneration are followed by a progressive generation of scar tissue, dieback of transected axons, and demyelination, creating an area inhibitory to regrowth and recovery. Two ways to combat this inhibition is to therapeutically target the extrinsic and intrinsic properties of the axon-scar environment. Scar tissue within and surrounding the lesion site can be broken down using an enzyme known as chondroitinase. Negative regulators of adult neuronal growth, such as Nogo, can be neutralized with antibodies. Both therapies greatly improve functional recovery in animal models. Alternatively, modifying the intrinsic growth properties of CNS neurons through gene therapy or pharmacotherapy has also shown promising axonal regeneration after injury. Despite these promising therapies, the main challenge of long-distance axon regeneration still remains; achieving a level of functional and organized connectivity below the level of the lesion that mimics the intact CNS.
This record has no associated files available for download.
More information
e-pub ahead of print date: 24 November 2012
Published date: 2012
Keywords:
CNS regeneration, glial scar , PTEN, spinal cord injury, integrins, Nogo
Organisations:
Biomedicine
Identifiers
Local EPrints ID: 411363
URI: http://eprints.soton.ac.uk/id/eprint/411363
ISSN: 0079-6123
PURE UUID: 882dad42-219d-405c-b173-0530b52e9694
Catalogue record
Date deposited: 19 Jun 2017 16:31
Last modified: 16 Mar 2024 04:28
Export record
Altmetrics
Contributors
Author:
Daniel J. Chew
Author:
James W. Fawcett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics